Spain · Delayed Price · Currency is EUR Clínica Baviera Statistics
Total Valuation
Clínica Baviera has a market cap or net worth of EUR 848.98 million. The enterprise value is 868.79 million.
| Market Cap | 848.98M |
| Enterprise Value | 868.79M |
Important Dates
The next estimated earnings date is Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | Jun 10, 2026 |
Share Statistics
Clínica Baviera has 16.02 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 16.02M |
| Shares Outstanding | 16.02M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 1.79% |
| Owned by Institutions (%) | 6.29% |
| Float | 2.19M |
Valuation Ratios
The trailing PE ratio is 20.18.
| PE Ratio | 20.18 |
| Forward PE | n/a |
| PS Ratio | 2.78 |
| PB Ratio | 7.65 |
| P/TBV Ratio | 12.15 |
| P/FCF Ratio | 18.13 |
| P/OCF Ratio | 11.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.49, with an EV/FCF ratio of 18.55.
| EV / Earnings | 20.65 |
| EV / Sales | 2.85 |
| EV / EBITDA | 10.49 |
| EV / EBIT | 14.32 |
| EV / FCF | 18.55 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.62.
| Current Ratio | 0.97 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 0.84 |
| Debt / FCF | 1.48 |
| Interest Coverage | 26.58 |
Financial Efficiency
Return on equity (ROE) is 41.02% and return on invested capital (ROIC) is 34.66%.
| Return on Equity (ROE) | 41.02% |
| Return on Assets (ROA) | 16.48% |
| Return on Invested Capital (ROIC) | 34.66% |
| Return on Capital Employed (ROCE) | 32.59% |
| Weighted Average Cost of Capital (WACC) | 7.71% |
| Revenue Per Employee | 163,841 |
| Profits Per Employee | 22,602 |
| Employee Count | 1,861 |
| Asset Turnover | 1.33 |
| Inventory Turnover | 46.59 |
Taxes
In the past 12 months, Clínica Baviera has paid 17.18 million in taxes.
| Income Tax | 17.18M |
| Effective Tax Rate | 28.57% |
Stock Price Statistics
The stock price has increased by +53.31% in the last 52 weeks. The beta is 0.71, so Clínica Baviera's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +53.31% |
| 50-Day Moving Average | 50.85 |
| 200-Day Moving Average | 46.83 |
| Relative Strength Index (RSI) | 61.17 |
| Average Volume (20 Days) | 3,407 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Clínica Baviera had revenue of EUR 304.91 million and earned 42.06 million in profits. Earnings per share was 2.63.
| Revenue | 304.91M |
| Gross Profit | 150.98M |
| Operating Income | 60.64M |
| Pretax Income | 60.11M |
| Net Income | 42.06M |
| EBITDA | 82.77M |
| EBIT | 60.64M |
| Earnings Per Share (EPS) | 2.63 |
Balance Sheet
The company has 50.32 million in cash and 69.16 million in debt, with a net cash position of -18.84 million or -1.18 per share.
| Cash & Cash Equivalents | 50.32M |
| Total Debt | 69.16M |
| Net Cash | -18.84M |
| Net Cash Per Share | -1.18 |
| Equity (Book Value) | 110.96M |
| Book Value Per Share | 6.87 |
| Working Capital | -2.13M |
Cash Flow
In the last 12 months, operating cash flow was 76.84 million and capital expenditures -30.01 million, giving a free cash flow of 46.83 million.
| Operating Cash Flow | 76.84M |
| Capital Expenditures | -30.01M |
| Depreciation & Amortization | 22.13M |
| Net Borrowing | -9.86M |
| Free Cash Flow | 46.83M |
| FCF Per Share | 2.92 |
Margins
Gross margin is 49.52%, with operating and profit margins of 19.89% and 13.80%.
| Gross Margin | 49.52% |
| Operating Margin | 19.89% |
| Pretax Margin | 19.71% |
| Profit Margin | 13.80% |
| EBITDA Margin | 27.15% |
| EBIT Margin | 19.89% |
| FCF Margin | 15.36% |
Dividends & Yields
This stock pays an annual dividend of 1.57, which amounts to a dividend yield of 2.96%.
| Dividend Per Share | 1.57 |
| Dividend Yield | 2.96% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 59.75% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 2.94% |
| Earnings Yield | 4.95% |
| FCF Yield | 5.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Clínica Baviera has an Altman Z-Score of 5.09 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.09 |
| Piotroski F-Score | 5 |